Cannabinoid Receptor Function & Alcoholism
This trial is active, not recruiting.
|Collaborator||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|
|Start date||July 2007|
|End date||October 2017|
|Trial size||36 participants|
|Trial identifier||NCT00624715, 0707002888|
This study attempts to characterize the effects of tetrahydrocannabinol (THC). Tetrahydrocannabinol is the active ingredient of marijuana, cannabis, "ganja", or "pot". This study will involve healthy volunteers who 1) have no history of alcoholism in their family or 2) have a family history of alcoholism. This study looks at individuals with or without a family history of alcoholism to determine if there is a difference between the two groups in the response to THC.
|Intervention model||crossover assignment|
|Masking||double blind (subject, caregiver, investigator, outcomes assessor)|
|Primary purpose||basic science|
Clinician Administered Dissociative Symptoms Scale, Visual Analog Scale ("High" rating), Rey Auditory Verbal Learning Test
time frame: Baseline, +15, +25 (RAVLT only), +70, +240
Male or female participants from 18 years up to 30 years old.
Inclusion Criteria: - Exposure to cannabis at least once Exclusion Criteria: - Pregnancy
|Official title||Cannabinoid Receptor Function & Alcoholism: Effects of Δ-9-THC|
|Principal investigator||Deepak D'Souza, M.D.|
Call for more information